Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of Clinical Progression, Prognostic Factors, and Quality of Life in Patients with Age-related Macular Degeneration.
Sponsor: University of Udine
Summary
The VERA-AMD study is a prospective, observational study designed to evaluate clinical progression, prognostic factors, and quality of life in patients with age-related macular degeneration (AMD). The study aims to analyze real-world clinical data to identify key predictors of disease progression and functional outcomes, with the goal of optimizing AMD management. The study involves 200 patients aged ≥50 with a confirmed diagnosis of AMD, monitored through routine clinical practice. Primary outcomes include progression rates to advanced AMD and changes in visual acuity, while secondary outcomes focus on retinal morphology and quality of life. Anti-VEGF therapy and AI-based fluid analysis will be integrated to explore their impact on disease progression and patient outcomes.
Official title: Evaluation of Clinical Progression, Prognostic Factors, and Quality of Life in Patients with Age-related Macular Degeneration (VERA-nAMD).
Key Details
Gender
All
Age Range
50 Years - 120 Years
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2024-10-01
Completion Date
2029-10-01
Last Updated
2025-03-27
Healthy Volunteers
No
Conditions
Locations (1)
Department of Ophthalmology
Udine, UD, Italy